Conference Coverage
Media
NewsNetwork
OncLive® TV
Peer Exchange
Insights
Podcasts
Rapid Readouts
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community

Register for a live broadcast to learn more about TRODELVY (sacituzumab govitecan-hziy) with Dr. Hope S. Rugo

SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology®
More >>
Select Topic:
Browse by Series:

PD-1 Inhibitors in NSCLC: Combination or Monotherapy

Panelists: David R. Gandara, MD, UC Davis Comprehensive Cancer Center; Everett E. Vokes, MD, University of Chicago Medicine
Published: Tuesday, Nov 20, 2018



Transcript:

SELECTED
LANGUAGE
Slider Left
Slider Right


Transcript:
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
x